ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Programmed cell death-ligand 1 expression in hepatocellular carcinoma and its correlation with clinicopathological characteristics

Mou, Haibo; Yang, Qiu-an; Yu, Lanfang; Wang, Ting; Liu, Kui; Shen, Rong; Pan, Xuedong; Dai, Yi; Wan, Qing; Zhou, Fangling; Qian, Lili; Chen, Donglin; Yau, Thomas; Dong, Xiaowei; Wang, Xuemei*; Wang, Shuang*吉林大学; 南方医科大学; 青岛大学; 山东大学
Journal of Gastroenterology and Hepatology2021-9DOI: 10.1111/jgh.15475
3被引6阅读
引用收藏
分享

摘要

Background and Aim Programmed cell death-ligand 1 (PD-L1) immunohistochemistry score has been approved as the predictive biomarker for anti-PD1/PD-L1 therapy in several advanced malignancies. Although its predictive role remained inconclusive in hepatocellular carcinoma, ongoing study of anti-PD1/PD-L1 therapy showed promising results. However, less is known about the PD-L1 immunohistochemistry score and factors correlated with it in hepatocellular carcinoma. We investigated PD-L1 immunohistochemistry scores in a large cohort of hepatocellular carcinoma, as well as its correlation with various clinical and genomic factors. @@@ Methods Immunohistochemistry was performed to detect the expression of PD-L1 protein in 315 hepatocellular carcinoma tissues. All slides were independently reviewed by three senior pathologists. Next-generation YS panel (450 genes) sequencing was performed on 309 patients. @@@ Results Higher PD-L1 expression as measured by combined positive score (CPS) was associated with increased Edmondson-Steiner grade (grade III vs II, P = 0.041) and TP53 mutations (P = 0.021). PD-L1 CPS had no correlation with tumor mutational burden (Spearman's correlation coefficient 0.067). PD-L1 CPS was not significantly associated with hepatitis B virus infection. @@@ Conclusions Our data indicated that patients with higher Edmondson-Steiner grade (grade III) had significantly higher PD-L1 CPS than patients with lower Edmondson-Steiner grade (grade II). Patients with TP53 mutations had significantly higher PD-L1 expression.

学科与关键词

关键词
E&#8211S gradeHepatocellular carcinomaImmunohistochemistryPD&#8208L1TP53Tumor mutational burden
相关
加载中…
  • PD-L1-Mediated Immunosuppression in Hepatocellular Carcinoma: Relationship with Macrophages Infiltration and Inflammatory Response Activity
    Guo, Shuang; Wang, Xinyue; Zhou, Hanxiao; Gao, Yue; Wang, Peng; Zhi, Hui; Sun, Yue; Zhang, Yakun; Gan, Jing; Xiao, Yun*; Ning, Shangwei*Biomolecules, 2022, 12(9): 1226.被引 4
  • Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer
    Li, Yue; Li, Chong; Jiang, Ya; Han, Xue; Liu, Sisi; Xu, Xiuxiu; Tang, Wanxiangfu; Ou, Qiuxiang; Bao, Hua; Wu, Xue; Shao, Yang; Xing, Minyan; Zhang, Yixiang*; Wang, Yuezhen*Journal of Oncology, 2022, 2022: 1763778.被引 1
  • Relationship Between Programmed Death Ligand 1 Expression and Other Clinicopathological Features in a Large Cohort of Gastric Cancer Patients
    Chen, Xinhua; Zhang, Huimin; Wang, Minghao; Liu, Hao; Hu, Yanfeng; Lin, Tian; Chen, Hao; Zhao, Mingli; Chen, Tao; Li, Guoxin; Yu, Jiang*; Zhao, Liying*Frontiers in Immunology, 2022, 13: 783695.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Gastroenterology and Hepatology
发表日期
2021-09
卷期
第 36 卷, 第 9 期
页码
2601-2609
DOI
10.1111/jgh.15475
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE

作者

  • M

    Mou, Haibo (第一作者)

    zhejiang shuren univ

  • Y

    Yang, Qiu-an

    shandong univ

查看全部 16 位作者收起作者
  • Y

    Yu, Lanfang

    zhejiang shuren univ

  • W

    Wang, Ting

    zhejiang shuren univ

  • L

    Liu, Kui

    qingdao univ

  • S

    Shen, Rong

    shandong prov hosp · shandong univ

  • P

    Pan, Xuedong

  • D

    Dai, Yi

  • W

    Wan, Qing

  • Z

    Zhou, Fangling

  • Q

    Qian, Lili

  • C

    Chen, Donglin

  • Y

    Yau, Thomas

  • D

    Dong, Xiaowei

    univ hong kong

  • W

    Wang, Xuemei (通讯)

    jilin univ

  • W

    Wang, Shuang (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417